US Patent 11129841 CD73 inhibitors
Patent 11129841 was granted and assigned to ORIC Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11129841 CD73 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.